Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of MEDECO is 0.6% (low). The 2023 annual accounts show equity of €2.42M and a net result of €-4.02M. Equity is growing by ~48.5% per year across the filed fiscal years. The company has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 6 annual accounts.
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.6%
Low
0%0,5%1,5%4%10%≥25%
Annual accounts: weaker financial profile
+Long track record
−Lower-risk legal form
−
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Filing behaviour
From the deposit records, complete market-wideDeadline passed, not yet counted as missing
The deadline for the year that closed on 31-12-2025 passed on 31-07-2026, 12 days ago. Our copy of the deposit register trails the National Bank (measured: median 14 days, p99 45 days), so we only call this filing missing from 45 days past the deadline.
Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 19-09-2025, 50 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
How we compute the deadline
The year end is derived from 10 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2024, that is 31-07-2025.
Deadline per financial year
| Year closed | Due by | Filed | Variance | Reference |
|---|---|---|---|---|
| 31-12-2025 | 31-07-2026 | nothing on record | not filed | - |
| 31-12-2024 | 31-07-2025 | 19-09-2025 | 50 d late | 2025-00498942 |
| 31-12-2023 | 31-07-2024 | 17-12-2024 | 139 d late | 2024-00618404 |
| 31-12-2022 | 31-07-2023 | 27-06-2023 | 34 d early | 2023-00161282 |
| 31-12-2021 | 31-07-2022 | 07-06-2022 | 54 d early | 2022-20052572 |
| 31-12-2020 | 31-07-2021 | 01-06-2021 | 60 d early | 2021-16100416 |
| 31-12-2019 | 31-07-2020 | 15-06-2020 | 46 d early | 2020-17700340 |
| 31-12-2018 | 31-07-2019 | 12-06-2019 | 49 d early | 2019-18700014 |
| 31-12-2017 | 31-07-2018 | 07-08-2018 | 7 d late | 2018-44300172 |
| 31-12-2016 | 31-07-2017 | 18-07-2017 | 13 d early | 2017-33400357 |
| 31-12-2015 | 31-07-2016 | 16-06-2016 | 45 d early | 2016-19000234 |
Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.
Trust signals
2 signalsLong-established
Founded in 2006, 20 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financials
Turnover€6.58M+5.4%
EBIT margin6.5%+1.8pp
Net result€-4.02M-719.4%
Working capital€-1.24M
Annual accounts & ratios
Source: NBB · 2023Annual accounts filed on 19-09-2025 with the NBB · fiscal year 2024 · volledig
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Equity: growth of ~48.5%/year over 6 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
€6.58M
+5.4%
18-23
€299k
+26.0%
18-23
€-4.02M
-719.4%
18-23
€-490k
-
18-23
€26.64M
-5.7%
18-23
€2.42M
-62.4%
18-23
€-1.24M
-
18-23
7
-7.1%
18-23
€673k
+17.7%
18-23
€0
-
18-23
€0
-
18-23
€24.22M
+11.0%
18-23
€3.01M
+433.9%
18-23
€21.00M
0.0%
18-23
0.59
-90.2%
18-23
0.59
-90.2%
18-23
9.1%
-60.1%
18-23
9.99
+195.1%
18-23
-165.7%
-2077.3%
18-23
-15.1%
-768.8%
18-23
-61.0%
-677.6%
18-23
4.8%
+132.8%
18-23
0.38
-66.8%
18-23
Figures by fiscal year
| Fiscal year | 2023 |
|---|---|
| Deposit | volledig |
| Revenue | €6.58M |
| EBITDA | - |
| Net profit | €-4.02M |
| Cash flow | - |
| Staff costs | €673k |
| Income taxes | €0 |
| Dividends | - |
| Total assets | €26.64M |
| Equity | €2.42M |
| Debt | €24.22M |
| of which ≤ 1y | €3.01M |
| of which > 1y | €21.00M |
| Working capital | €-1.24M |
| Employees (FTE) | 6.5 |
Ratios (computed)
| 2023 | |
|---|---|
| Current ratio | 0.59 |
| Quick ratio | 0.59 |
| Working capital ratio | -4.7% |
| Solvency | 9.1% |
| Debt / equity | 9.99 |
| Long-term debt ratio | 8.66 |
| Interest coverage | - |
| Gross margin | 30.6% |
| Net margin | -61.0% |
| ROA | -15.1% |
| ROE | -165.7% |
| EBITDA margin | - |
| Days sales outstanding | 96d |
| Days payable outstanding | 96d |
| Inventory turnover | - |
| Days inventory (DSI) | 0d |
Balance-sheet composition 2023
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2023 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €26.64M |
| Fixed assets | 21/28 | €24.87M |
| Financial fixed assets | 28 | €24.87M |
| Current assets | 29/58 | €1.77M |
| Stocks & contracts in progress | 3 | €0 |
| Amounts receivable within one year | 40/41 | €1.73M |
| Cash & bank | 54/58 | €30k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €26.64M |
| Equity | 10/15 | €2.42M |
| Contributions / capital | 10/11 | €5.06M |
| Reserves | 13 | €94k |
| Accumulated profits (losses) | 14 | €-2.73M |
| Amounts payable | 17/49 | €24.22M |
| Amounts payable after one year | 17 | €21.00M |
| Amounts payable within one year | 42/48 | €3.01M |
| Trade debts payable within one year | 44 | €1.20M |
| Income statement | ||
| Turnover | 70 | €6.58M |
| Operating result | 9901 | €430k |
| Financial income | 75 | €0 |
| Financial charges | 65 | €798k |
| Result before taxes | 9903 | €-4.02M |
| Income taxes | 67/77 | €0 |
| Net result for the period | 9904 | €-4.02M |
| Result to be appropriated | 9905 | €-4.02M |
You're seeing the latest fiscal year only. Unlock 4 prior years (figures + ratios) with a paid plan.
See plans →
Ratios computed by Checked.
Health barometer
FY 2023 · computed12
/ 100
Critical
Computed from 4 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Unlock the full score breakdown, per-year score history and the indicative credit limit from Kantoor S.
See plans →Computed by Checked from the NBB filing for FY 2023. Indicative, not credit advice.
Directors
Directors & mandates
10 directorsCurrent directors & mandates
-
Current15-07-2024 → present
2 events
- 15-07-2024 Appointed· Director
- 15-07-2024 Appointed· Managing director
-
Mediq Nederland BVLegal entityDirector· perm. rep.: Marcia LuijendijkState Gazette act 23144989 (14-11-2023)Current01-10-2023 → present
7 events
- 01-10-2023 Mandate renewed· Director
- 30-09-2023 Resigned· Director
- 22-10-2021 Appointed· Director
- 14-10-2019 Appointed· Managing director
- 01-02-2019 Resigned· Director
- 01-02-2019 Appointed· Director
- 01-12-2017 Appointed· Director
-
Mediq Nederland B.V.Legal entityDirector· perm. rep.: Marcia LuijendijkState Gazette act 24014082 (23-01-2024)Current30-06-2023 → present
Historic, not recently confirmed (2)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
-
Medeco B.V.Legal entityManaging director· perm. rep.: Ronald HoozemansState Gazette act 16086261 (24-06-2016)Not recently confirmedlast confirmed in an act from 2016
2 events
- 23-05-2016 Appointed· Managing director
- 01-06-2013 Mandate renewed· Director
-
Not recently confirmedlast confirmed in an act from 2007
Permanent representatives (1)
These people represent a legal-person director (a management company, for instance). They hold no board mandate of their own and do not count as directors.
-
Permanent representative- → 14-10-2019
Former directors (5)
-
Former01-09-2021 → 01-08-2024
4 events
- 01-08-2024 Resigned· Director
- 01-08-2024 Resigned· Managing director
- 01-09-2021 Appointed· Director
- 01-09-2021 Appointed· Managing director
-
Former01-12-2017 → 31-08-2021
4 events
- 31-08-2021 Resigned· Director
- 31-08-2021 Resigned· Managing director
- 29-06-2018 Appointed· Managing director
- 01-12-2017 Appointed· Director
-
Medeco BVLegal entityDirector· perm. rep.: Ronald HoozemansState Gazette act 17168149 (01-12-2017)Former- → 01-12-2017
-
Former23-05-2016 → 01-12-2017
3 events
- 01-12-2017 Resigned· Director
- 23-05-2016 Appointed· Director
- 23-05-2016 Appointed· Managing director
-
Former- → 23-05-2016
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Statutory auditor
3 auditors| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| KPMG Bedrijfsrevisoren BVCurrent Statutory auditor · represented by BEX Ellemarie |
- | 15-01-2026 → present |
| KPMG Bedrijfsrevisoren CVBA Company auditor · represented by Louis Vercammen succeeded by KPMG Réviseurs d'Entreprises in 2023 |
- | 22-07-2013 → 01-10-2023 |
| KPMG Réviseurs d'Entreprises Statutory auditor · represented by Ellemarie Bex succeeded by KPMG Bedrijfsrevisoren BV in 2026 |
- | 01-10-2023 → 15-01-2026 |
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Insolvency mandates
No insolvency mandates (liquidators, administrators) on record for this company.
Legal Structure
| NACE primary | Groothandel in farmaceutische en medische artikelen(46460) |
| Legal form | Public limited company(014) |
| Incorporation | 03-02-2006 |
| Status | Active |
| Postal code | 2550 |
Structure & network
Connections & network
2 connected companiesGroup structure
We sit on their board · 1 location
→
Network connections
Shared address
→
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Ownership & control
1 partyMEDECOBE 0879.130.202
controls
Where this company holds controlthis company sits on their board1
1 location
Each band states what its claims rest on. A board seat is influence over the board, not ownership. Court mandates (receiver, interim administrator) and liquidation mandates do not link companies and are therefore absent here; they belong under Directors & mandates.
Locations & real estate
Registered office
from the Crossroads BankCannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Satenrozen 192550 KontichEstablishment units
1 locationMedeco
since 20062.152.025.370
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area435 m²
Real-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11024G0007/00E000 | Flanders | 435 m² | - | - |
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Publications
Lifecycle & Insolvency Signals
No insolvency signals in the Belgian State Gazette
Belgisch Staatsblad · acts
20 acts Capital history · 2
13-12-2021
v3.2
30-01-2018
v3.2
Address history · 2
10-05-2024
v3.2
11-03-2014
v3.2
All acts · 20
updated 6 months ago
2026
15-01-2026 BEX Ellemarie reappointed as statutory auditor
2024
29-11-2024 Ellemarie Bex reappointed as statutory auditor
04-09-2024 2 directors appointed, 2 resigning
- Julie Steyt, Bestuurder
- Julie Steyt, Gedelegeerd bestuurder
- Rudi Van Bever, Bestuurder
- Rudi Van Bever, Gedelegeerd bestuurder
Summary:
v3.2
10-05-2024 Registered office moved from Zaventem to Kontich
23-01-2024 Marcia Luijendijk reappointed as director
2023
14-11-2023 1 resigning, 1 reappointed
2022
21-11-2022 Melissa Carton reappointed as statutory auditor
2021
13-12-2021 Capital increase of €4,000,000 to €5,061,500
22-10-2021 3 directors appointed, 2 resigning
- Rudi van Bever, Bestuurder
- Rudi van Bever, Gedelegeerd bestuurder
- Arjen Linders, Bestuurder
- Marc Grasso, Bestuurder
- Marc Grasso, Gedelegeerd bestuurder
Summary:
v3.2
2020
24-01-2020 Articles of association amended
Summary:
v3.2
2019
20-12-2019 1 director appointed, 1 resigning
- Arjen Linders, Gedelegeerd bestuurder
- Marc Grasso, Vaste vertegenwoordiger
Summary:
v3.2
06-06-2019 1 director appointed, 1 resigning
2018
29-06-2018 1 director appointed, 1 resigning
- Marc Grasso, Gedelegeerd bestuurder
- Ronald Hoozemans, Gedelegeerd bestuurder
Summary:
v3.2
30-01-2018 Capital decrease of €1,000,000 to €1,061,500
2017
01-12-2017 2 directors appointed, 2 resigning
- Marc Grasso, Bestuurder
- Ronald Hoozemans, Bestuurder
- Sjoerd van Hecke, Bestuurder
- Ronald Hoozemans, Bestuurder
Summary:
v3.2
2016
24-06-2016 3 directors appointed, 1 resigning, 1 reappointed
- Sjoerd van Hecke, Bestuurder
- Ronald Hoozemans, Gedelegeerd bestuurder
- Sjoerd van Hecke, Gedelegeerd bestuurder
- Gerard Treffers, Bestuurder
- Louis Vercammen, Commissaris
Summary:
v3.2
2015
09-09-2015 Change in the board of directors
Summary:
v3.2
2014
11-03-2014 Registered office moved from Turnhout to Zaventem
- Campus Blairon 110, 2300 Turnhout → Ikaroslaan 19, 1930 Zaventem
Summary:
v3.2
2013
22-07-2013 2 reappointed
2007
06-04-2007 René van Valburg appointed as managing director
Analysis
Snowflake analysis
financial profile on 5 axes34
/ 100
Fragile profile, watch profitability in particular.
All 5 axes are computed from data Checked has read.
Health
12
Profitability
0
Solvency
8
Growth
50
Stability
100
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
TryWhat are the main risks?Any recent red flags?Compare to sector peers
Coming soonAI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Coming soon
The brief is drafted by our AI model at Anthropic in the US, from this dossier's public data. Nothing that identifies you is sent along and we do not keep the brief. Indicative, not legal or investment advice. How it works
Credit advice
verdict per customer and amountSimilar
Similar companies
Comparable size, same sectorBE 0787.324.947 · Sint-Joost-ten-Node
BE 0869.917.477 · Anderlecht
BE 0762.935.682 · Anderlecht
BE 0804.183.349 · Braine-l'Alleud
BE 0403.026.585 · Sint-Agatha-Berchem
We hold annual accounts for 195 of the 1,895 companies in this sector. 88 of them are within a factor 10 of this company's equity.
Company registry
Company registry (CBE)
Crossroads BankActivities
Groothandel in farmaceutische producten46460Groothandel in farmaceutische en medische artikelen46460Groothandel in farmaceutische producten51460
Primary activity highlighted.
Names & trade names
| Legal nameNL | MEDECO |
Registered office
Satenrozen 19
2550 Kontich, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.